Abstract: Deoxyuridine derivatives of the formula (I) where R1 is H or various substituents; D is —NHCO—, —CONH—, -0-, —C(?O)—, —CH?CH, —C?C—, —NR5—; R4 is hydrogen or various substituents; R5 is H, C1-C4 alkyl, C1-C4 alkanoyl; E is Si or C; R6, R7 and R8 are independently selected from C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl or a stable monocyclic, bicyclic or tricyclic ring system; G is —O—, —S—, —CHR10—, —C(?O)—; J is —CH2—, or when G is CHR10 may also be —O— or —NH—; R10 is H, F, —CH3, —CH2NH2, —CH2OH; —OHR11 is H, F, —CH3, —CH2NH2, —CH2OH, —CH(OH)CH3, CH(NH3)CH3; or R10 and R11 together define an olefinic bond, or together form a —CH2-group, thereby defining a cis or trans cyclopropyl group; have utility in the prophylaxis or treatment of protozoal diseases such as malaria.

Abstract: Deoxyuridine derivatives of the formula where A is O, S or CH2; B is O, S or CHR3; R1 is H, or various substituents; R2 is H, F; R3 is H, F, OH, NH2; or R2 and R3 together form a chemical bond; D is —NHCO—, —CONH—, —O—, —C(?O)—, —CH?CH, —C?C—, —NR5—; R4 is hydrogen or various substituents; R5 is H, C1-C4 alkyl, C1-C4 alkanoyl; E is Si or C; R6, R7 and R8 are independently selected from C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, or a stable monocyclic, bicyclic or tricyclic ring system have utility in the prophylaxis o treatment of parasitic diseases such as malaria

Abstract: 4-Amino-1-((2R,3S,4S,5R)-5-azido-4-hydroxy-5-hydroxymethyl-3-methyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one (22) and prodrugs thereof are hepatitis C (HCV) polymerase inhibitors. Also disclosed are compositions and methods for inhibiting HCV and treating HCV-mediated diseases, processes for making the compounds and synthetic intermediates employed in the process.

Abstract: A motor controller for controlling an electric motor including a soft starter and a human-machine interface for control and configuration of the soft starter. The soft starter includes a visual display and a selector associated with the visual display. A method to configure a motor controller for controlling an electric motor, including a soft starter and a human-machine interface for control and configuration of the soft starter. A computer program and graphic user interface for carrying out the method.

Abstract: Deoxyuridine derivatives of Formula (I?); where A is O, S or CH2; B is O, S or CHR3; R1 is H, or various substituents; R2 is H, F; R3 is H, F, OH, NH2; or R2 and R3 together form a chemical bond; D is —NHCO—, —CONH—, —O—, —C(?O)—, —CH?CH, —C?C—, —NR5—; R4 is hydrogen or various substituents; R5 is H, C1-C4 alkyl, C1-C4 alkanoyl; E is Si or C; R6, R7 and R8 are independently selected from C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, or a stable monocyclic, bicyclic or tricyclic ring system have utility in the prophylaxis of treatment of parasitic diseases such as malaria.

Abstract: A method for reducing the influence of a DC component in a load current of an asynchronous three-phase motor, in which the voltages of two of the three phases are controlled by adjusting firing angles of semiconductor devices of the type turning-off at zero-crossing of the current therethrough comprises the steps carried out for each said controlled phase: detecting turn-off times of the semiconductor devices, calculating a value of a change of firing angle of the semiconductor devices needed for changing the length of the time period between two subsequent turn-off times for compensating for the influence of a DC component, and determining the firing angle of said semiconductor devices in dependence of the result of this calculation.

Abstract: A method of controlling a current of a three-phase electric motor with a three-phase controller. The firing angles are adjusted so as to leave a range of firing angles in which DC components appear.

Abstract: Methods and novel intermediates for the preparation of and the treatment with acyclic nucleoside derivatives of the formula: where one of R1 and R2 is an amino acid acyl group and the other of R1 and R2 is a —C(O)C3-C21 saturated or monounsaturated, optionally substituted alkyl and R3 is OH or H.

Abstract: The present invention discloses a double TRU (Transceiver Unit) (45). The output signals from the power amplifiers (64, 84) are combined to one common output signal provided to an antenna arrangement (91). A DSP (Digital Signal Processor) (52, 72) of each TRU (50, 70) comprises means for a constant-envelope modulation scheme (54, 74) and a non-constant envelope scheme (53, 73). The DSP:s (52, 72) select the modulation scheme according to modulation information (49, 69). In such a way, a switching between different modulation schemes can be performed even on a time-slot basis. For non-constant-envelope modulation, the modulated signal is separated into two component signals. Each TRU (50, 70) takes care of the amplification of one component. A phase compensation of at least one of the TRU:s (50, 70) is performed in order to correct for different paths of phases of the power amplifiers (64, 84). The non-constant envelope modulated signal can also be a multi-carrier signal, e.g.

Abstract: Deoxyuridine derivatives of the formula (I) where R1 is H or various substituents; D is —NHCO—, —CONH—, -0-, —C(?O)—, —CH?CH, —C?C—, —NR5—; R4 is hydrogen or various substituents; R5 is H, C1-C4 alkyl, C1-C4 alkanoyl; E is Si or C; R6, R7 and R8 are independently selected from C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl or a stable monocyclic, bicyclic or tricyclic ring system; G is —O—, —S—, —CHR10—, —C(?O)—; J is —CH2—, or when G is CHR10 may also be —O— or —NH—; R10 is H, F, —CH3, —CH2NH2, —CH2OH; —OHR11 is H, F, —CH3, —CH2NH2, —CH2OH, —CH(OH)CH3, CH(NH3)CH3; or R10 and R11 together define an olefinic bond, or together form a —CH2-group, thereby defining a cis or trans cyclopropyl group; have utility in the prophylaxis or treatment of protozoal diseases such as malaria.

Abstract: Deoxyuridine derivatives of Formula (I?); where A is O, S or CH2; B is O, S or CHR3; R1 is H, or various substituents; R2 is H, F; R3 is H, F, OH, NH2; or R2 and R3 together form a chemical bond; D is —NHCO—, —CONH—, —O—, —C(?O)—, —CH?CH, —C?C—, —NR5—; R4 is hydrogen or various substituents; R5 is H, C1-C4 alkyl, C1-C4 alkanoyl; E is Si or C; R6, R7 and R8 are independently selected from C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, or a stable monocyclic, bicyclic or tricyclic ring system have utility in the prophylaxis of treatment of parasitic diseases such as malaria.

Abstract: Methods and novel intermediates for the preparation of and the treatment with acyclic nucleoside derivatives of the formula: where one of R1 and R2 is an amino acid acyl group and the other of R1 and R2 is a —C(O)C3-C21 saturated or monounsaturated, optionally substituted alkyl and R3 is OH or H.

Abstract: 4-Amino-1-((2R,3S,4S,5R)-5-azido-4-hydroxy-5-hydroxymethyl-3-methyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one (22) and prodrugs thereof are hepatitis C (HCV) polymerase inhibitors. Also disclosed are compositions and methods for inhibiting HCV and treating HCV-mediated diseases, processes for making the compounds and synthetic intermediates employed in the process.

Abstract: An apparatus for monitoring and control of one or more electric motors, including a motor controller, equipped with a soft starter. The soft starter includes memory for storing operations and event data, as well as a human-machine interface for making the event information available for display and/or analysis. A method to monitor and diagnose a condition of an electric motor controlled by a motor controller equipped with a soft starter including a human-machine interface. A computer program for carrying out the method.

Abstract: A motor controller for controlling an electric motor including a soft starter and a human-machine interface for control and configuration of the soft starter. The soft starter includes a visual display and a selector associated with the visual display. A method to configure a motor controller for controlling an electric motor, including a soft starter and a human-machine interface for control and configuration of the soft starter. A computer program and graphic user interface for carrying out the method.

Abstract: An apparatus for monitoring and control of one or more electric motors, including a motor controller, equipped with a soft starter. The soft starter includes memory for storing operations and event data, as well as a human-machine interface for making the event information available for display and/or analysis. A method to monitor and diagnose a condition of an electric motor controlled by a motor controller equipped with a soft starter including a human-machine interface. A computer program for carrying out the method.

Abstract: A method of treating HBV or HIV infections comprising administering to an individual an effective amount of the compound of formula IId?: wherein R2 is the residue of an aliphatic L-amino acid, p is 0, 1, or 2-20, and q is 0, or a pharmaceutically acceptable salt thereof.

Abstract: The present invention discloses a double TRU (Transceiver Unit) (45). The output signals from the power amplifiers (64, 84) are combined to one common output signal provided to an antenna arrangement (91). A DSP (Digital Signal Processor) (52, 72) of each TRU (50, 70) comprises means for a constant-envelope modulation scheme (54, 74) and a non-constant envelope scheme (53, 73). The DSP:s (52, 72) select the modulation scheme according to modulation information (49, 69). In such a way, a switching between different modulation schemes can be performed even on a time-slot basis. For non-constant-envelope modulation, the modulated signal is separated into two component signals. Each TRU (50, 70) takes care of the amplification of one component. A phase compensation of at least one of the TRU:s (50, 70) is performed in order to correct for different paths of phases of the power amplifiers (64, 84). The non-constant envelope modulated signal can also be a multi-carrier signal, e.g.